Expertise in
4
conditions

Dr. Karen Mccoy

Pediatric Pulmonology
Nationwide Children's Hospital
700 Childrens Dr, 
Columbus, OH 
Expertise in
4
conditions
Nationwide Children's Hospital
700 Childrens Dr, 
Columbus, OH 

Overview

Karen Mccoy is a Pediatric Pulmonologist in Columbus, Ohio. Dr. Mccoy is highly rated in 4 conditions, according to our data. Her top areas of expertise are Cystic Fibrosis, Asthma, Exocrine Pancreatic Insufficiency, Gastroesophageal Reflux Disease (GERD), and Lung Transplant.

Her clinical research consists of co-authoring 84 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatric Pulmonology

Licenses

Pediatrics in OH

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Ohio Health Group
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Nationwide Children's Hospital
700 Childrens Dr, Columbus, OH 43205
Other Locations
Office
555 S 18th St, Columbus, OH 43205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Procedure
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other, Biological
Study Drug: AP-PA02 Bacteriophage
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Drug
Study Drug: ELX-02 Ribosomal-Selective Glycoside
Study Phase: Phase 2
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

84 Total Publications

CFTR mutation leads to intrinsic dysfunction in neutrophils from people with Cystic Fibrosis.
CFTR mutation leads to intrinsic dysfunction in neutrophils from people with Cystic Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Similar Doctors
Expertise in
6
conditions
Dr. Kavitha Kotha
Pediatric Pulmonology
Expertise in
6
conditions
Dr. Kavitha Kotha
Pediatric Pulmonology

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (81.0 miles away)
614-722-4750
Languages Spoken:
English
See accepted insurances

Kavitha Kotha is a Pediatric Pulmonologist in Columbus, Ohio. Dr. Kotha is highly rated in 6 conditions, according to our data. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Jaundice.

Expertise in
4
conditions
Dr. John S. Heintz
Pediatric Pulmonology | Pediatrics
Expertise in
4
conditions
Dr. John S. Heintz
Pediatric Pulmonology | Pediatrics
150 W Main St, 
New Albany, OH 
 (82.4 miles away)
614-722-2000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

John Heintz is a Pediatric Pulmonologist and a Pediatrics provider in New Albany, Ohio. Dr. Heintz is highly rated in 4 conditions, according to our data. His top areas of expertise are Secondary Immunodeficiency (SID), Cystic Fibrosis, Newborn Jaundice, and Jaundice. Dr. Heintz is currently accepting new patients.

Expertise in
3
conditions
Dr. Shahid Sheikh
Pediatric Pulmonology
Expertise in
3
conditions
Dr. Shahid Sheikh
Pediatric Pulmonology

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (81.0 miles away)
614-722-2180
Languages Spoken:
English
See accepted insurances

Shahid Sheikh is a Pediatric Pulmonologist in Columbus, Ohio. Dr. Sheikh is highly rated in 3 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Asthma, Bronchopulmonary Dysplasia, Short Rib-Polydactyly Syndrome Type 1, and Lung Transplant.

Frequently Asked Questions about Dr. Karen Mccoy

How do I make an appointment with Dr. Karen Mccoy?

You can book an appointment with Dr. Karen Mccoy by calling their office at 614-722-4766. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Karen Mccoy a top-rated expert for Cystic Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karen Mccoy is classified as an Elite expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Karen Mccoy specialize in?

While Dr. Karen Mccoy is a Pediatric Pulmonology, they have specific expertise in Cystic Fibrosis, Asthma, and Exocrine Pancreatic Insufficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Pulmonology.

Does Dr. Karen Mccoy participate in research or clinical trials?

Yes. Dr. Karen Mccoy has published 84 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Karen Mccoy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Karen Mccoy accept my insurance?

Dr. Karen Mccoy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-722-4766 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccoy's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile